Innovent Biologics
company
Funding Round
Post-IPO Equity
Money Raised
$ 2.42B
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Sanofi | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Nov 29, 2016 | Series D | $ 260M | Milestone | Detail |
| Nov 16, 2012 | Series B | $ 30M | Lilly Asia Ventures | Detail |
| Jan 22, 2015 | Series C | $ 115M | Lilly Asia Ventures | Detail |
| Apr 27, 2018 | Series E | $ 150M | Lilly Asia Ventures | Detail |
